Invention Grant
US08541584B2 3-(1,2,3-triazol-4-yl) pyrrolo [2,3-b] pyridine derivatives
有权
3-（1,2,3-三唑-4-基）吡咯并[2,3-b]吡啶衍生物
![3-(1,2,3-triazol-4-yl) pyrrolo [2,3-b] pyridine derivatives](/docs/US/2013-09-24/US08541584B2/abs.jpg.600x600.jpg)
- Patent Title: 3-(1,2,3-triazol-4-yl) pyrrolo [2,3-b] pyridine derivatives
- Patent Title (中): 3-（1,2,3-三唑-4-基）吡咯并[2,3-b]吡啶衍生物
-
Application No.: US13318518Application Date: 2010-04-08
-
Publication No.: US08541584B2Publication Date: 2013-09-24
- Inventor: Dieter Dorsch , Margarita Wucherer-Plietker , Thomas J. J. Mueller , Eugen Merkul
- Applicant: Dieter Dorsch , Margarita Wucherer-Plietker , Thomas J. J. Mueller , Eugen Merkul
- Applicant Address: DE Darmstadt
- Assignee: Merck Patent GmbH
- Current Assignee: Merck Patent GmbH
- Current Assignee Address: DE Darmstadt
- Agency: Millen, White, Zelano & Branigan, P.C.
- Priority: DE102009019962 20090505
- International Application: PCT/EP2010/002207 WO 20100408
- International Announcement: WO2010/127754 WO 20101111
- Main IPC: C07D471/02
- IPC: C07D471/02 ; A61K31/44 ; A61K31/535
![3-(1,2,3-triazol-4-yl) pyrrolo [2,3-b] pyridine derivatives](/abs-image/US/2013/09/24/US08541584B2/abs.jpg.150x150.jpg)
Abstract:
Compounds of the formula (I), in which R1, R2 and R3 have the meanings indicated in claim (1), are inhibitors of PDK1 and cell proliferation/cell vitality and can be employed for the treatment of tumors.
Public/Granted literature
- US20120053178A1 3-(1,2,3-Triazol-4-yl) pyrrolo [2,3-b] pyridine derivatives Public/Granted day:2012-03-01
Information query
